TY - JOUR
AU - 
TI - NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma
JF - Clinical Cancer Research
DO - 10.1158/1078-0432.ccr-14-2206
DA - 2015-05-31
UR - https://www.deepdyve.com/lp/unpaywall/nrf2-pathway-activation-and-adjuvant-chemotherapy-benefit-in-lung-ZHS8AaEeg9
DP - DeepDyve
ER -